Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02

  • STATUS
    Not Recruiting
  • End date
    Sep 21, 2021
  • participants needed
    600
  • sponsor
    Allergan
Updated on 25 January 2021
Investigator
Clinical Trials Registry Team
Primary Contact
CIAD Moron (0.0 mi away) Contact
+395 other location
diabetes
diabetes mellitus
type 2 diabetes mellitus
relamorelin
diabetic gastroparesis

Summary

This study will evaluate the safety and efficacy of Relamorelin compared to placebo in patients with diabetic gastroparesis. Patients will report daily severity scores of their diabetic gastroparesis symptoms.

Details
Condition Diabetes Mellitus, Gastroparesis, Gastropathy, Stomach Discomfort, Diabetes Prevention, Diabetes Mellitus Types I and II, Diabetic Gastroparesis, Diabetes (Pediatric)
Treatment Placebo, Relamorelin
Clinical Study IdentifierNCT03426345
SponsorAllergan
Last Modified on25 January 2021

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note